Replies to post #500731 on Anavex Life Sciences Corp (AVXL)

[Guzzi62]

Agreed.

Investor14 and Doc keep on beating the drum about a confirmatory trial of some sorts!

I call bullshit, why on earth would EMA do that for?? There is absolutely no need to do that considering they approved the "Maps"

Now France is talking about stop funding lecanemab because it's not effective and expensive for the country.
Funnily enough, France has a lady professor (Dr. Audrey Gabelle), that speaks very warmly about 2-73, hmmmmmm!!

UK (not in the EU) has approved lecanemab but don't pay for it.
NHS rejection: The National Institute for Health and Care Excellence (NICE), which assesses whether drugs can be offered on the NHS, did not recommend lecanemab for public funding.
NICE determined that the drug's benefits, which it considered to be relatively small, did not justify the high costs of the medicine, infusions, and monitoring.

[powerwalker]

Hoskuld, once the OK is given to sell Blarcamesine, Anavex will announce within 30 days a partnership with, most likely, one or more members of its Consortium, closing out any buy-out by other BP firms.


ANAVEX NOW ... MONO-STYLE!!!

[williamssc]

An approval for a relatively inexpensive AD oral therapy that requires no expensive infrastructure (imaging machines, IV centers, frequent appointments) would be a massive win for the EU.

I think this is where the rubber meets the road in our MAA decision. AD is an expensive unmet public need that's looking for a better solution than current IV treatments due to costs and the logistical nightmare folks would endure. Inexpensive safe oral delivery is a no-brainer.